AR080515A1 - Vacunas recombinantes del virus de la enfermedad del pie y de la boca (fmd1) y sus usos - Google Patents
Vacunas recombinantes del virus de la enfermedad del pie y de la boca (fmd1) y sus usosInfo
- Publication number
- AR080515A1 AR080515A1 ARP110100797A ARP110100797A AR080515A1 AR 080515 A1 AR080515 A1 AR 080515A1 AR P110100797 A ARP110100797 A AR P110100797A AR P110100797 A ARP110100797 A AR P110100797A AR 080515 A1 AR080515 A1 AR 080515A1
- Authority
- AR
- Argentina
- Prior art keywords
- fmdv
- fmd1
- virus
- foot
- antigen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
- C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/517—Plant cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12111—Orbivirus, e.g. bluetongue virus
- C12N2720/12134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Vacunas o composiciones contra el FMDV. La vacuna o composicion puede ser una vacuna o composicion que contenga antígenos del FMDV. La solicitud también abarca vectores recombinantes que codifican y expresan antígenos, epítopos o inmunogenos del FMDV, que pueden emplearse para proteger a los animales, en particular, a los ovinos, bovinos, caprinos o porcinos, contra el FMDV. Reivindicacion 2: La composicion de acuerdo con la reivindicacion 1, en la cual el antígeno del FMDV se selecciona del grupo que consiste en FMDV P1-3C, FMDV P1, FMDV VP0, FMDV VP1, FMDV VP3, FMDV VP2 y FMDV VP4. Reivindicacion 3: La composicion de acuerdo con la reivindicacion 1 o 2, en la cual el antígeno del FMDV se expresa en una planta o en una microalga. Reivindicacion 19: Un cultivo de una microalga o planta de lenteja de agua transformada en forma estable, transformado con un gen que expresa a un antígeno del FMDV o fragmento o variante del mismo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31316410P | 2010-03-12 | 2010-03-12 | |
US36636310P | 2010-07-21 | 2010-07-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR080515A1 true AR080515A1 (es) | 2012-04-11 |
Family
ID=43923659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP110100797A AR080515A1 (es) | 2010-03-12 | 2011-03-14 | Vacunas recombinantes del virus de la enfermedad del pie y de la boca (fmd1) y sus usos |
Country Status (15)
Country | Link |
---|---|
US (3) | US20110236416A1 (es) |
EP (4) | EP2944322B1 (es) |
JP (1) | JP2013522300A (es) |
CN (2) | CN103687614B (es) |
AR (1) | AR080515A1 (es) |
AU (1) | AU2011224188B2 (es) |
BR (2) | BR112012023852B1 (es) |
CA (2) | CA2792117C (es) |
ES (2) | ES2617743T3 (es) |
IL (3) | IL221781B (es) |
MA (1) | MA34087B1 (es) |
NZ (2) | NZ702145A (es) |
RU (1) | RU2575599C2 (es) |
WO (2) | WO2011112945A2 (es) |
ZA (1) | ZA201206619B (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0809435A2 (pt) | 2007-03-27 | 2014-09-09 | Sea Lane Biotechnologies Llc | Constructos e bibliotecas que compreendem sequências de cadeia leve substituida de anticorpos |
JP2012526839A (ja) | 2009-05-13 | 2012-11-01 | シー レーン バイオテクノロジーズ, エルエルシー | インフルエンザウイルスに対する中和分子 |
WO2013016714A1 (en) | 2011-07-28 | 2013-01-31 | Sea Lane Biotechnologies | Sur-binding proteins against erbb3 |
EP2793940B1 (en) | 2011-12-22 | 2018-11-14 | i2 Pharmaceuticals, Inc. | Surrogate binding proteins |
RU2693431C2 (ru) | 2012-09-05 | 2019-07-02 | Медикаго Инк. | Получение пикорнавирусоподобных частиц в растениях |
US20140090108A1 (en) * | 2012-09-18 | 2014-03-27 | Freydoun Garabagi | Vectors and Methods For Enhancing Recombinant Protein Expression in Plants |
KR20210088754A (ko) | 2013-03-15 | 2021-07-14 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | 구제역 바이러스 (fmdv) 공통 단백질, 그에 대한 코딩 서열 및 그로부터 제조된 백신 |
MX365410B (es) * | 2013-03-26 | 2019-05-31 | The Pirbright Inst | Cápsides estabilizadas del virus de la fiebre aftosa. |
US10872313B2 (en) | 2015-06-02 | 2020-12-22 | ROCA Medical Ltd. | Method for repurposing NDC codes in a pharmaceutical database for venom derived allergens involved in venom immunotherapy |
KR102526219B1 (ko) * | 2014-09-23 | 2023-04-26 | 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 | Fmdv 재조합 백신 및 이의 용도 |
CN111944023B (zh) * | 2014-11-07 | 2022-08-19 | 普莱柯生物工程股份有限公司 | 一种抗o型口蹄疫的疫苗组合物及其制备方法和应用 |
US10548974B2 (en) | 2015-06-02 | 2020-02-04 | ROCA Medical Ltd. | Therapeutic treatment kit for allergies based on DNA profiles |
US10369215B2 (en) | 2015-06-02 | 2019-08-06 | ROCA Medical Ltd. | Predilution sets for distributing antigens |
US11103570B2 (en) * | 2015-06-15 | 2021-08-31 | Bavarian Nordic A/S | Recombinant modified vaccinia virus Ankara (MVA) foot and mouth disease virus (FMDV) vaccine |
US9913891B2 (en) * | 2015-11-23 | 2018-03-13 | Merial Inc. | FMDV and E2 fusion proteins and uses thereof |
WO2017097875A1 (en) * | 2015-12-08 | 2017-06-15 | Danmarks Tekniske Universitet | Kit-of-parts for use in a prime-boost vaccination strategy to protect cloven-footed animals against foot-and-mouth disease virus infection |
TWI730037B (zh) * | 2016-01-26 | 2021-06-11 | 日商富士軟片和光純藥股份有限公司 | 光硬化方法,及用於該光硬化方法之化合物和組成物 |
TWI760322B (zh) | 2016-01-29 | 2022-04-11 | 美商百靈佳殷格翰動物保健美國有限公司 | 重組腺病毒載體裝載之fmdv疫苗及其用途 |
WO2017182958A1 (en) * | 2016-04-19 | 2017-10-26 | Csir | Plant-produced chimaeric orbivirus vlps |
US10385319B2 (en) | 2016-09-08 | 2019-08-20 | The Governement of the United States of America, as represented by the Secretary of Homeland Security | Modified foot-and-mouth disease virus 3C proteases, compositions and methods thereof |
US10435695B2 (en) | 2016-09-08 | 2019-10-08 | The Government of the United States of America, as represented by the Secretary of Homeland Security | Fusion protein comprising Gaussia luciferase, translation interrupter sequence, and interferon amino acid sequences |
WO2019023920A1 (zh) * | 2017-08-01 | 2019-02-07 | 金普诺安生物科技(苏州)有限公司 | 一种口蹄疫病毒样颗粒疫苗及其制备方法 |
KR102165358B1 (ko) * | 2017-12-29 | 2020-10-14 | (주)플럼라인생명과학 | 구제역 바이러스 a형 백신 조성물 |
CN108273054B (zh) * | 2018-01-25 | 2020-11-17 | 中国农业科学院兰州兽医研究所 | 猪口蹄疫病毒O型、A型Fc多肽双价疫苗及其制备方法和应用 |
CN111233984B (zh) * | 2018-11-29 | 2022-08-12 | 普莱柯生物工程股份有限公司 | 一种o型口蹄疫病毒样颗粒抗原、及其疫苗组合物、制备方法和应用 |
PE20230833A1 (es) | 2020-05-27 | 2023-05-19 | Us Agriculture | Cepas vivas atenuadas de la fiebre aftosa modificadas por desoptimizacion y usos de estas |
Family Cites Families (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
US5110587A (en) | 1981-12-24 | 1992-05-05 | Health Research, Incorporated | Immunogenic composition comprising synthetically modified vaccinia virus |
US5174993A (en) | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
US4769330A (en) | 1981-12-24 | 1988-09-06 | Health Research, Incorporated | Modified vaccinia virus and methods for making and using the same |
US4603112A (en) | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
US5505941A (en) | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
JPS60500673A (ja) | 1983-03-08 | 1985-05-09 | コモンウエルス セラム ラボラトリ−ズ コミツシヨン | 抗原活性を有するアミノ酸配列 |
US5380831A (en) | 1986-04-04 | 1995-01-10 | Mycogen Plant Science, Inc. | Synthetic insecticidal crystal protein gene |
US4761373A (en) | 1984-03-06 | 1988-08-02 | Molecular Genetics, Inc. | Herbicide resistance in plants |
DE3584341D1 (de) | 1984-08-24 | 1991-11-14 | Upjohn Co | Rekombinante dna-verbindungen und expression von polypeptiden wie tpa. |
US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
US4968615A (en) | 1985-12-18 | 1990-11-06 | Ciba-Geigy Corporation | Deoxyribonucleic acid segment from a virus |
US4963481A (en) | 1985-12-18 | 1990-10-16 | Genetics Institute Inc | Promoter system |
HU209143B (en) | 1986-01-08 | 1994-03-28 | Rhone Poulenc Agrochimie | Method for producing nitrilase specific to halogenated benzonitryl, sequences containing its coding gene and cells containing said sequences |
DE3730599A1 (de) | 1986-09-12 | 1988-07-07 | Genentech Inc | Verfahren zur kontinuierlichen herstellung von heterologen proteinen in eukaryontischen wirtszellen |
GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
DE3743138A1 (de) | 1987-12-18 | 1989-09-14 | Mayr Christian Gmbh & Co Kg | Schleifringlose, elektromagnetische ueberlastkupplung |
CA1341245C (en) | 1988-01-12 | 2001-06-05 | F. Hoffmann-La Roche Ag | Recombinant vaccinia virus mva |
US5990387A (en) | 1988-06-10 | 1999-11-23 | Pioneer Hi-Bred International, Inc. | Stable transformation of plant cells |
NZ230375A (en) | 1988-09-09 | 1991-07-26 | Lubrizol Genetics Inc | Synthetic gene encoding b. thuringiensis insecticidal protein |
DE69033816T2 (de) | 1989-02-24 | 2002-08-08 | Monsanto Technology Llc | Synthetische pflanzengene und verfahren zu ihrer herstellung |
US5879918A (en) | 1989-05-12 | 1999-03-09 | Pioneer Hi-Bred International, Inc. | Pretreatment of microprojectiles prior to using in a particle gun |
GB8915572D0 (en) * | 1989-07-07 | 1989-08-23 | Natural Environment Res | Use of bluetongue virus proteins as vaccine components |
US5690938A (en) * | 1989-07-07 | 1997-11-25 | Oravax, Inc. | Oral immunization with multiple particulate antigen delivery system |
AU651101B2 (en) | 1990-04-18 | 1994-07-14 | Plant Genetic Systems N.V. | Modified bacillus thuringiensis insecticidal-crystal protein genes and their expression in plant cells |
US5932782A (en) | 1990-11-14 | 1999-08-03 | Pioneer Hi-Bred International, Inc. | Plant transformation method using agrobacterium species adhered to microprojectiles |
ATE247163T1 (de) | 1991-03-07 | 2003-08-15 | Virogenetics Corp | Gentechnologisch hergestellter stamm für impfstoffe |
TW261517B (es) | 1991-11-29 | 1995-11-01 | Mitsubishi Shozi Kk | |
JP2952041B2 (ja) | 1992-07-27 | 1999-09-20 | パイオニア ハイ−ブレッド インターナショナル,インコーポレイテッド | 培養ダイズ細胞のagrobacterium媒介形質転換の改良法 |
WO1995014098A1 (en) | 1993-11-19 | 1995-05-26 | Biotechnology Research And Development Corporation | Chimeric regulatory regions and gene cassettes for expression of genes in plants |
JPH11504631A (ja) | 1995-04-25 | 1999-04-27 | バイカル インコーポレイテッド | Dna/脂質複合体の単一バイアル製剤 |
US5846946A (en) | 1996-06-14 | 1998-12-08 | Pasteur Merieux Serums Et Vaccins | Compositions and methods for administering Borrelia DNA |
FR2751224B1 (fr) | 1996-07-19 | 1998-11-20 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs |
FR2751227B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives |
FR2751228B1 (fr) | 1996-07-19 | 1998-11-20 | Rhone Merieux | Vaccin polynucleotidique bovin pour voie intradermique |
FR2751225B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique aviaire |
FR2751226B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies du cheval |
FR2751229B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins |
AU4992197A (en) | 1996-10-11 | 1998-05-11 | Regents Of The University Of California, The | Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
US6045774A (en) | 1997-01-10 | 2000-04-04 | Epicyte Pharmaceutical Inc. | J chain polypeptide targeting molecule linked to an imaging agent |
US5981840A (en) | 1997-01-24 | 1999-11-09 | Pioneer Hi-Bred International, Inc. | Methods for agrobacterium-mediated transformation |
HUP0004589A3 (en) | 1997-06-30 | 2003-08-28 | Centre Nat Rech Scient | Improved method for transferring nucleic acid into the striped muscle and combination therefor |
US7161064B2 (en) * | 1997-08-12 | 2007-01-09 | North Carolina State University | Method for producing stably transformed duckweed using microprojectile bombardment |
US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
FR2778858B1 (fr) | 1998-05-20 | 2000-06-16 | Oreal | Emulsion e/h/e stable et son utilisation comme composition cosmetique et/ou dermatologique |
US8003772B2 (en) | 1999-01-14 | 2011-08-23 | Martek Biosciences Corporation | Chimeric PUFA polyketide synthase systems and uses thereof |
FR2801607B1 (fr) | 1999-11-26 | 2001-12-28 | Merial Sas | Pneumovirus du canard et vaccins correspondants |
US6852705B2 (en) | 2000-01-21 | 2005-02-08 | Merial | DNA vaccines for farm animals, in particular bovines and porcines |
FR2810888B1 (fr) * | 2000-06-29 | 2004-07-30 | Merial Sas | Vaccin contre la fievre aphteuse |
US8022270B2 (en) * | 2000-07-31 | 2011-09-20 | Biolex Therapeutics, Inc. | Expression of biologically active polypeptides in duckweed |
US7632983B2 (en) | 2000-07-31 | 2009-12-15 | Biolex Therapeutics, Inc. | Expression of monoclonal antibodies in duckweed |
CA2417415C (en) | 2000-07-31 | 2012-10-09 | Biolex, Inc. | Expression of biologically active polypeptides in duckweed |
US7018164B2 (en) | 2000-09-06 | 2006-03-28 | The Charles Machine Works, Inc. | Auxiliary pipe loading device |
TWI350854B (en) | 2001-04-16 | 2011-10-21 | Martek Biosciences Corp | Product and process for transformation of thraustochytriales microorganisms |
IL158984A0 (en) | 2001-05-30 | 2004-05-12 | Biolex Inc | Use of duckweed in high throughput screening |
RU2207877C1 (ru) * | 2001-11-09 | 2003-07-10 | Всероссийский научно-исследовательский институт экспериментальной ветеринарии им. Я.Р. Коваленко | Вакцина для профилактики и лечения трихофитии крупного, мелкого рогатого скота и оленей |
US6680200B2 (en) | 2002-02-22 | 2004-01-20 | Biolex, Inc. | Led array for illuminating cell well plates and automated rack system for handling the same |
EP1485492B1 (en) * | 2002-03-19 | 2011-12-21 | Stichting Dienst Landbouwkundig Onderzoek | Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta(1,4)-n-acetylglucosaminyltransferase iii) expression in plants |
US7176024B2 (en) | 2003-05-30 | 2007-02-13 | Biolex, Inc. | Bioreactor for growing biological materials supported on a liquid surface |
PL1651265T3 (pl) | 2003-07-24 | 2008-10-31 | Merial Ltd | Formulacje szczepionek zawierających emulsję olej w wodzie |
US7527960B2 (en) * | 2004-06-25 | 2009-05-05 | Merial Limited | Avipox recombinants expressing foot and mouth disease virus genes |
CN100582122C (zh) * | 2006-05-12 | 2010-01-20 | 北京宝麦德生物医药科技有限责任公司 | O型口蹄疫病毒多表位粘膜免疫疫苗及其应用 |
US7862821B2 (en) | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
CN101082051A (zh) * | 2006-06-02 | 2007-12-05 | 广东出入境检验检疫局检验检疫技术中心 | 重组口蹄疫病毒多肽片段及其应用 |
CN101121938B (zh) * | 2007-03-23 | 2010-10-06 | 中国农业科学院兰州兽医研究所 | 一种口蹄疫抗原的制备方法 |
EP3037526B1 (en) * | 2007-11-26 | 2018-03-14 | London School of Hygiene and Tropical Medicine | Method for producing vaccinal viral strain of a virus of the reoviridae family |
JP2011509661A (ja) | 2007-11-27 | 2011-03-31 | メディカゴ インコーポレイテッド | ヘマグルチニンを発現するトランスジェニック植物において産生された組換え型インフルエンザウイルス様粒子(vlp) |
AP3215A (en) * | 2008-04-16 | 2015-04-30 | Onderstepoort Biolog Products Ltd | Inactivated live-attenuated bluetongue virus vaccine |
TW201010719A (en) * | 2008-08-19 | 2010-03-16 | Wyeth Corp | Immunological composition |
EP3542815A1 (en) * | 2008-11-28 | 2019-09-25 | Boehringer Ingelheim Animal Health USA Inc. | Recombinant avian influenza vaccine and uses thereof |
KR101939014B1 (ko) | 2009-03-16 | 2019-01-15 | 디에스엠 아이피 어셋츠 비.브이. | 라비린툴로바이코타문 미생물에서의 단백질 생산 |
-
2011
- 2011-03-11 EP EP15167872.9A patent/EP2944322B1/en active Active
- 2011-03-11 ES ES11711411.6T patent/ES2617743T3/es active Active
- 2011-03-11 CN CN201180020099.6A patent/CN103687614B/zh active Active
- 2011-03-11 RU RU2012143624/10A patent/RU2575599C2/ru active
- 2011-03-11 CA CA2792117A patent/CA2792117C/en active Active
- 2011-03-11 NZ NZ702145A patent/NZ702145A/en not_active IP Right Cessation
- 2011-03-11 US US13/046,255 patent/US20110236416A1/en not_active Abandoned
- 2011-03-11 NZ NZ602278A patent/NZ602278A/en not_active IP Right Cessation
- 2011-03-11 ES ES11709301T patent/ES2795148T3/es active Active
- 2011-03-11 BR BR112012023852-3A patent/BR112012023852B1/pt not_active IP Right Cessation
- 2011-03-11 EP EP11709301.3A patent/EP2544716B1/en active Active
- 2011-03-11 BR BR112012023046A patent/BR112012023046B1/pt active IP Right Grant
- 2011-03-11 EP EP11711411.6A patent/EP2545067B1/en active Active
- 2011-03-11 EP EP16171113.0A patent/EP3093025B1/en active Active
- 2011-03-11 US US13/046,317 patent/US9345759B2/en active Active
- 2011-03-11 CN CN201180020079.9A patent/CN103492410A/zh active Pending
- 2011-03-11 JP JP2013500104A patent/JP2013522300A/ja active Pending
- 2011-03-11 CA CA2792118A patent/CA2792118C/en active Active
- 2011-03-11 WO PCT/US2011/028115 patent/WO2011112945A2/en active Application Filing
- 2011-03-11 WO PCT/US2011/028131 patent/WO2011112955A1/en active Application Filing
- 2011-03-11 AU AU2011224188A patent/AU2011224188B2/en not_active Ceased
- 2011-03-11 MA MA35244A patent/MA34087B1/fr unknown
- 2011-03-14 AR ARP110100797A patent/AR080515A1/es active IP Right Grant
-
2012
- 2012-09-04 IL IL221781A patent/IL221781B/en active IP Right Grant
- 2012-09-04 ZA ZA2012/06619A patent/ZA201206619B/en unknown
-
2016
- 2016-04-14 US US15/098,350 patent/US20170022255A1/en not_active Abandoned
-
2018
- 2018-11-25 IL IL263249A patent/IL263249B/en active IP Right Grant
- 2018-11-25 IL IL263253A patent/IL263253B/en active IP Right Grant
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR080515A1 (es) | Vacunas recombinantes del virus de la enfermedad del pie y de la boca (fmd1) y sus usos | |
AR102006A1 (es) | Vacunas recombinantes contra el virus de la fiebre aftosa (fmdv) y sus usos | |
UY30385A1 (es) | Vacuna recombinante contra el virus de la lengua azul | |
DOP2012000187A (es) | Antigeno ndv recombinante y usos del mismo | |
CL2018003769A1 (es) | Una cepa del virus atenuado de la peste porcina africana desarrollada racionalmente que, protege contra la infección por el virus parental georgia 2007 aislado. | |
CL2017000987A1 (es) | Partículas tipo virus modificadas de cmv | |
PE20141482A1 (es) | Vectores recombinantes de hvt que expresan antigenos de patogenos de aves y sus usos | |
AR053711A1 (es) | Combinacion de vacunas para circovirus porcina y helicobacter y metodos de utilizacion | |
AR080313A1 (es) | Composiciones de virus de moquillo canino (cdv) recombinante y sus usos | |
AR069882A1 (es) | Circovirus porcino, molecula de acido nucleico aislada que lo codifica, composicion inmunogenica que lo comprende, vector que comprende por lo menos una molecula de acido nucleico exogena que codifica una proteina de circovirus porcino y metodos para inmunizar un cerdo contra la infeccion virica o e | |
GT201100145A (es) | Vacuna recombinante para influenza aviar y sus usos | |
MX2013010620A (es) | Adenovirus de aves del serotipo 4 (fadv-4) no patogénico y vector viral del mismo. | |
CO2018010874A2 (es) | Vacuna de virus de zika atenuado vivo | |
CO2018003460A2 (es) | Vacunas de partículas tipo virus (vlp) contra el parvovirus canino (cpv) y sus usos | |
ES2723776T3 (es) | Nuevas cepas de rotavirus humano y vacunas | |
PE20221792A1 (es) | Vacuna en vector recombinante de adenovirus aviar serotipo 9 | |
RU2015100269A (ru) | Реассортантные btv и ahsv вакцины | |
CL2021000485A1 (es) | Una cepa mutante de salmonella enteritidis; procedimiento para generar la cepa mutante; vacuna recombinante aviar de salmonella enteritidis, divisional de la solicitud 201903108 | |
AR109540A1 (es) | Moléculas promotoras para expresar antígenos virales | |
NI201700080A (es) | Composiciones de vacuna para el virus del dengue y métodos de uso de las mismas. | |
AR066823A1 (es) | Aumento del rendimiento en plantas por modulacion del factor zmrr10-p de transcripcion de garp | |
AR106792A1 (es) | Proteínas de fusión de e2 y fmdv y sus usos | |
MX343848B (es) | Vacuna de her2 dna como tratamiento adjunto para canceres en animales de compañía. | |
Kusumarahayu et al. | Molecular characterisation of Newcastle disease virus exotic isolate in east Java, Indonesia. | |
AR105819A1 (es) | Vacunas recombinantes contra el calicivirus felino (fcv) y sus usos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |